[F1] Flash Talks (1)

13:55 〜 13:56Immunology

[F1-16] Integrative Optimization of TLR9 and STING Agonist-Based Strategies in Cancer Immunotherapy

*Mai Onaga¹, Burcu Temizoz¹, Seigo Akaeda², Kou Hioki³, Kaiwen Liu¹, Tomoya Hayashi¹, Hideo Negishi¹, Kouji Kobiyama⁴, Peter D. Katsikis³, Cevayir Coban¹, Ken J Ishii¹ (1. The University of Tokyo (Japan), 2. Yokohama City University (Japan), 3. Erasmus University Medical Center (Netherlands), 4. University of California San Diego (United States of America))

キーワード：

Cancer、TLR9、STING

閲覧にはパスワードが必要です

ログイン

または